Imprivata (IMPR) Reports In-Line Q3 EPS

Imprivata (NYSE: IMPR) reported Q3 EPS of ($0.16), in-line with the analyst estimate of ($0.16). Revenue for the quarter came in at $25.3 million versus the consensus estimate of $23.3 million.

Imprivata sees FY2014 EPS of ($0.11)-($0.09), versus the consensus of ($0.09). Imprivata sees FY2014 revenue of $26-27 million, versus the consensus of $26 million.

Imprivata sees FY2014 EPS of ($1.19)-($1.16), versus the consensus of ($1.43). Imprivata sees FY2014 revenue of $94-95 million, versus the consensus of $92.8 million.

Omar Hussain, CEO of Imprivata, commented, “Our record third quarter revenues were driven by both new and existing customers, along with key competitive takeaways. We continue to see strong demand in our business driven by Meaningful Use Stage 2 initiatives, hospitals deploying Virtual Desktop Infrastructures, and the increasing adoption of EMRs globally. Our growth and success continue to validate that Imprivata solutions are important to our customers as they balance IT security with provider productivity.”

For earnings history and earnings-related data on Imprivata (IMPR) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Vivos Therapeutics posts 35% revenue gain but widens net loss
• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance